Literature DB >> 21754051

4-(4-Nitro-benz-yl)morpholine.

Ling-Ling Yang, Ren-Lin Zheng, Guo-Bo Li, Qi-Zheng Sun, Yong-Mei Xie.   

Abstract

In the title compound, C(11)H(14)N(2)O(3), an inter-molecular inter-action between a nitro group O atom and a neighboring benzene ring helps to stabilize the crystal structure [N⋯centroid = 3.933 (2) Å]. No classical hydrogen bonds are observed in the crystal packing.

Entities:  

Year:  2011        PMID: 21754051      PMCID: PMC3099983          DOI: 10.1107/S1600536811005964

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of 4-(4-nitro­benz­yl)morpholine derivatives, see: Lan et al. (2010 ▶); Bavetsias et al. (2010 ▶). For the synthesis, see: Tsou et al. (2008 ▶). For standard bond lengths, see: Allen et al. (1987 ▶).

Experimental

Crystal data

C11H14N2O3 M = 222.24 Monoclinic, a = 6.1371 (2) Å b = 8.2535 (4) Å c = 21.9867 (9) Å β = 94.929 (3)° V = 1109.58 (8) Å3 Z = 4 Mo Kα radiation μ = 0.10 mm−1 T = 293 K 0.40 × 0.30 × 0.25 mm

Data collection

Oxford Diffraction Xcalibur Eos diffractometer Absorption correction: multi-scan (CrysAlis PRO; Oxford Diffraction, 2006 ▶) T min = 0.946, T max = 1.0 6059 measured reflections 2264 independent reflections 1640 reflections with I > 2σ(I) R int = 0.018

Refinement

R[F 2 > 2σ(F 2)] = 0.044 wR(F 2) = 0.106 S = 1.04 2264 reflections 145 parameters H-atom parameters constrained Δρmax = 0.12 e Å−3 Δρmin = −0.13 e Å−3 Data collection: CrysAlis PRO (Oxford Diffraction, 2006 ▶); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: OLEX2 (Dolomanov et al., 2009 ▶); software used to prepare material for publication: OLEX2. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811005964/vm2073sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811005964/vm2073Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C11H14N2O3F(000) = 472
Mr = 222.24Dx = 1.330 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.7107 Å
Hall symbol: -P 2ybcCell parameters from 2399 reflections
a = 6.1371 (2) Åθ = 3.1–29.2°
b = 8.2535 (4) ŵ = 0.10 mm1
c = 21.9867 (9) ÅT = 293 K
β = 94.929 (3)°Block, yellow
V = 1109.58 (8) Å30.40 × 0.30 × 0.25 mm
Z = 4
Oxford Diffraction Xcalibur Eos diffractometer2264 independent reflections
Radiation source: fine-focus sealed tube1640 reflections with I > 2σ(I)
graphiteRint = 0.018
Detector resolution: 16.0874 pixels mm-1θmax = 26.4°, θmin = 3.1°
ω scansh = −7→7
Absorption correction: multi-scan (CrysAlis PRO; Oxford Diffraction, 2006)k = −8→10
Tmin = 0.946, Tmax = 1.0l = −25→27
6059 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.044Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.106H-atom parameters constrained
S = 1.04w = 1/[σ2(Fo2) + (0.0423P)2 + 0.1325P] where P = (Fo2 + 2Fc2)/3
2264 reflections(Δ/σ)max < 0.001
145 parametersΔρmax = 0.12 e Å3
0 restraintsΔρmin = −0.13 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.40024 (19)0.31753 (14)0.53296 (5)0.0556 (3)
O2−0.4376 (2)−0.42771 (17)0.28701 (7)0.0751 (4)
O3−0.1642 (2)−0.57082 (16)0.32340 (8)0.0808 (5)
N10.33645 (19)0.14840 (16)0.41946 (6)0.0417 (3)
N2−0.2491 (2)−0.44089 (19)0.30912 (6)0.0530 (4)
C1−0.1173 (2)−0.29260 (19)0.31894 (7)0.0413 (4)
C2−0.2096 (2)−0.1454 (2)0.30324 (7)0.0461 (4)
H2−0.3521−0.13920.28530.055*
C3−0.0870 (2)−0.0064 (2)0.31460 (7)0.0467 (4)
H3−0.14840.09410.30440.056*
C40.1268 (2)−0.0148 (2)0.34109 (7)0.0420 (4)
C50.2166 (2)−0.1668 (2)0.35492 (7)0.0468 (4)
H50.3605−0.17430.37180.056*
C60.0965 (3)−0.3056 (2)0.34414 (7)0.0471 (4)
H60.1576−0.40660.35360.057*
C70.2629 (3)0.1353 (2)0.35452 (7)0.0493 (4)
H7A0.38930.13250.33090.059*
H7B0.17710.23020.34210.059*
C80.5018 (2)0.2751 (2)0.43006 (8)0.0499 (4)
H8B0.44090.37850.41620.060*
H8A0.62560.25130.40690.060*
C90.5767 (3)0.2851 (2)0.49693 (9)0.0550 (5)
H9A0.64510.18350.51000.066*
H9B0.68530.37010.50330.066*
C100.1559 (2)0.1839 (2)0.45620 (8)0.0502 (4)
H10A0.04660.09910.45070.060*
H10B0.08790.28550.44300.060*
C110.2381 (3)0.1952 (2)0.52265 (8)0.0566 (5)
H11B0.11650.21910.54660.068*
H11A0.29920.09160.53610.068*
U11U22U33U12U13U23
O10.0660 (7)0.0481 (7)0.0523 (7)−0.0032 (6)0.0017 (6)−0.0124 (6)
O20.0609 (8)0.0800 (10)0.0819 (10)−0.0136 (7)−0.0089 (7)−0.0130 (8)
O30.0861 (10)0.0489 (9)0.1079 (12)−0.0023 (7)0.0107 (8)0.0089 (8)
N10.0422 (7)0.0462 (8)0.0372 (7)−0.0052 (6)0.0053 (5)−0.0017 (6)
N20.0584 (9)0.0565 (10)0.0451 (8)−0.0045 (7)0.0101 (7)−0.0050 (7)
C10.0460 (9)0.0465 (10)0.0314 (8)0.0000 (7)0.0045 (6)−0.0033 (7)
C20.0416 (8)0.0573 (11)0.0385 (9)0.0041 (7)−0.0026 (7)−0.0006 (8)
C30.0516 (9)0.0469 (10)0.0408 (9)0.0081 (7)−0.0002 (7)0.0019 (7)
C40.0474 (9)0.0495 (10)0.0294 (8)0.0016 (7)0.0055 (6)−0.0017 (7)
C50.0399 (8)0.0607 (12)0.0394 (9)0.0034 (8)−0.0001 (7)−0.0014 (8)
C60.0502 (9)0.0476 (10)0.0435 (9)0.0104 (7)0.0044 (7)0.0016 (8)
C70.0542 (9)0.0555 (11)0.0386 (9)−0.0047 (8)0.0065 (7)0.0027 (8)
C80.0463 (9)0.0492 (11)0.0546 (11)−0.0072 (7)0.0059 (7)0.0007 (8)
C90.0523 (10)0.0501 (11)0.0610 (12)−0.0059 (8)−0.0047 (8)−0.0050 (9)
C100.0457 (9)0.0588 (11)0.0468 (10)−0.0069 (7)0.0080 (7)−0.0067 (8)
C110.0632 (11)0.0609 (12)0.0472 (10)−0.0092 (9)0.0128 (8)−0.0105 (9)
O1—C91.421 (2)C5—H50.9300
O1—C111.4218 (19)C5—C61.372 (2)
O2—N21.2210 (17)C6—H60.9300
O3—N21.2214 (17)C7—H7A0.9700
N1—C71.4641 (19)C7—H7B0.9700
N1—C81.4616 (19)C8—H8B0.9700
N1—C101.456 (2)C8—H8A0.9700
N2—C11.473 (2)C8—C91.504 (2)
C1—C21.372 (2)C9—H9A0.9700
C1—C61.384 (2)C9—H9B0.9700
C2—H20.9300C10—H10A0.9700
C2—C31.383 (2)C10—H10B0.9700
C3—H30.9300C10—C111.507 (2)
C3—C41.3911 (19)C11—H11B0.9700
C4—C51.393 (2)C11—H11A0.9700
C4—C71.509 (2)
O1—C9—C8111.83 (13)C4—C3—H3119.6
O1—C9—H9A109.3C4—C5—H5119.4
O1—C9—H9B109.3C4—C7—H7A109.3
O1—C11—C10111.71 (14)C4—C7—H7B109.3
O1—C11—H11B109.3C5—C4—C7119.67 (13)
O1—C11—H11A109.3C5—C6—C1118.75 (15)
O2—N2—O3123.32 (15)C5—C6—H6120.6
O2—N2—C1118.31 (15)C6—C1—N2118.95 (15)
O3—N2—C1118.38 (14)C6—C5—C4121.20 (14)
N1—C7—C4111.73 (13)C6—C5—H5119.4
N1—C7—H7A109.3H7A—C7—H7B107.9
N1—C7—H7B109.3C8—N1—C7111.09 (12)
N1—C8—H8B109.6C8—C9—H9A109.3
N1—C8—H8A109.6C8—C9—H9B109.3
N1—C8—C9110.15 (14)H8B—C8—H8A108.1
N1—C10—H10A109.6C9—O1—C11109.49 (13)
N1—C10—H10B109.6C9—C8—H8B109.6
N1—C10—C11110.07 (13)C9—C8—H8A109.6
C1—C2—H2120.6H9A—C9—H9B107.9
C1—C2—C3118.87 (14)C10—N1—C7111.73 (12)
C1—C6—H6120.6C10—N1—C8108.57 (13)
C2—C1—N2119.30 (14)C10—C11—H11B109.3
C2—C1—C6121.76 (15)C10—C11—H11A109.3
C2—C3—H3119.6H10A—C10—H10B108.2
C2—C3—C4120.88 (15)C11—C10—H10A109.6
C3—C2—H2120.6C11—C10—H10B109.6
C3—C4—C5118.51 (15)H11B—C11—H11A107.9
C3—C4—C7121.81 (15)
  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors.

Authors:  Ping Lan; Wan-Na Chen; Gao-Keng Xiao; Ping-Hua Sun; Wei-Min Chen
Journal:  Bioorg Med Chem Lett       Date:  2010-09-24       Impact factor: 2.823

3.  4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).

Authors:  Hwei-Ru Tsou; Mercy Otteng; Tritin Tran; M Brawner Floyd; Marvin Reich; Gary Birnberg; Kristina Kutterer; Semiramis Ayral-Kaloustian; Malini Ravi; Ramaswamy Nilakantan; Mary Grillo; John P McGinnis; Sridhar K Rabindran
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

4.  Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate.

Authors:  Vassilios Bavetsias; Jonathan M Large; Chongbo Sun; Nathalie Bouloc; Magda Kosmopoulou; Mizio Matteucci; Nicola E Wilsher; Vanessa Martins; Jóhannes Reynisson; Butrus Atrash; Amir Faisal; Frederique Urban; Melanie Valenti; Alexis de Haven Brandon; Gary Box; Florence I Raynaud; Paul Workman; Suzanne A Eccles; Richard Bayliss; Julian Blagg; Spiros Linardopoulos; Edward McDonald
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

  4 in total
  3 in total

1.  4-(4-Nitro-phen-yl)morpholine.

Authors:  Li-Jiao Wang; Wei-Wei Li; Sheng-Yong Yang; Li Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-31

2.  5-Meth-oxy-2-{[4-(morpholin-4-yl)phen-yl]imino-meth-yl}phenol.

Authors:  K Dhahagani; K Manvizhi; G Chakkaravarthi; G Anbalagan; G Rajagopal
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27

3.  2,4-Diiodo-6-{[4-(morpholin-4-yl)phenyl]iminomethyl}phenol.

Authors:  K Manvizhi; G Chakkaravarthi; G Anbalagan; G Rajagopal
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.